Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Alembic Pharmaceuticals share price rose 2 percent in the opening trade on November 17 following the company received final approval from USFDA for angina drug. At 09:19am, Alembic Pharmaceuticals was ...

Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Recent research from Gartner found that two-thirds of marketing leaders reported moderate to significant challenges demonstrating the impact of marketing campaigns on business outcomes to key ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Use this on an equipment item to convert it to an Image Item for Fusion. Cannot be used on items that are not subject to Fusion, such as arm and waist armor as well as accessories. Performing Fusion ...

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.

Alembic Pharmaceuticals Inc., the US subsidiary of Alembic Pharmaceuticals, has acquired Utility Therapeutics Ltd in a $12 million deal to strengthen its presence in the US market. Alembic will begin ...

Shares of Alembic Pharmaceuticals soared more than 12 percent in intra-day trade on Monday, June 30, after the company announced that it had secured final approval from the US Food and Drug ...

Alembic Pharmaceuticals share price rose more than 10 percent intraday on June 30 after the company received USFDA approval for Doxorubicin Hydrochloride Injection. At 13:22 hrs, Alembic ...